James C. Momtazee
About James C. Momtazee
James C. Momtazee's Role at KKR & Co., Inc.
James C. Momtazee has served in various roles at KKR & Co., Inc. since 1996. He was instrumental in forming KKR's health care industry group in 2001 and was later promoted to Head of the Health Care Team for the Americas Private Equity platform in January 2009. During his tenure, he was an active member of KKR's Americas Private Equity Investment Committee. He also chaired the Health Care Strategic Growth and the Health Care Royalty & Income Investment Committees.
James C. Momtazee's Contributions to KKR's Health Care Investments
From 2001 to 2019, under James C. Momtazee's leadership, KKR committed over $50 billion in capital to the health care sector. One of the most significant transactions during his tenure was the $33 billion acquisition of HCA, Inc. in 2006, marking one of the largest investments in the firm's history.
Healthcare Board Memberships of James C. Momtazee
James C. Momtazee has served on the Board of Directors for multiple health care companies. His board memberships have included PRA Health Sciences, Inc., Envision Healthcare, Heartland Dental, Ajax Health, Global Medical Response, BrightSpring Health Services, Covenant Surgical Partners, Entellus Medical, Inc., EchoNous, Spirox, Inc., Arbor Pharmaceuticals, Lake Region Medical, HCA Healthcare, Jazz Pharmaceuticals, and Alliance Imaging. These roles have enabled him to influence critical decisions in the health care sector.
Current Board Roles Held by James C. Momtazee
James C. Momtazee currently serves on the Board of Directors of BridgeBio, Apollo Therapeutics, Kriya Therapeutics, and the Medical Device Manufacturers Association. His involvement in these organizations continues to shape the strategic direction and growth within the health care and therapeutic sectors.